Dolacen

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dolacen

Quick Facts About Dolacen

Property Description
Active Ingredient Diclofenac (typically as the sodium or potassium salt)
Forms Tablets, capsules, suppositories, injectable solutions, topical gels
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
General Purpose Relief of pain, reduction of inflammation, and fever-lowering (antipyretic) action
Origin Synthetic (chemically derived)

What is Dolacen and Its Pharmacological Class?

Dolacen is a trade name for a medicine containing the chemically synthesized active ingredient Diclofenac. This medication is definitively classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), belonging specifically to the chemical group known as Phenylacetic Acid Derivatives. This classification is widely recognized and supported by extensive pharmacological studies, confirming that the drug’s core function is to modulate the body’s inflammatory response.

Its designation as an NSAID confirms its fundamental mechanism: it blocks the synthesis of specific substances in the body, primarily prostaglandins, which are essential chemical mediators responsible for generating signals of pain, inflammation, and fever. The drug's action is to limit the production of these inflammatory chemicals, which translates to a reduction in swelling and discomfort.

The Active Substance: Composition and Available Forms

The core composition of Dolacen centers on the active ingredient Diclofenac, generally prepared as a stabilized salt, such as Diclofenac Sodium or Diclofenac Potassium, making it a single-ingredient product. The substance is manufactured in diverse dosage forms to accommodate various delivery methods. These forms, including conventional oral tablets and capsules, specialized topical gels and patches, suppositories for rectal use, and injectable solutions for parenteral administration, provide a key differentiating factor in its therapeutic application compared to many other NSAIDs.

This comprehensive range ensures the Diclofenac can be delivered via the oral, topical, rectal, or parenteral routes. Each form utilizes an appropriate base/vehicle, such as a solid matrix or a hydro-alcoholic gel, tailored for systemic or localized action.

General Purpose: What Dolacen is Designed to Relieve

Dolacen is broadly designed to provide symptomatic relief by deploying its triple functional capacity: acting as an analgesic (relieving pain), an anti-inflammatory agent (reducing swelling), and an antipyretic (lowering fever). The overall therapeutic utility is rooted in its ability to directly intervene in the biochemical processes that cause inflammation, effectively easing physical discomfort and improving functional capacity where inflammation is present.

Regulatory References

  1. NIH - Diclofenac (StatPearls)

What side effects are possible with Dolacen?

Serious Warnings and Contraindications

Dolacen (diclofenac), as a Nonsteroidal Anti-inflammatory Drug (NSAID), carries mandatory warnings from regulatory bodies concerning significant risks, particularly with systemic (oral) use. Treatment should use the lowest effective dose for the shortest duration possible to mitigate these risks.

  • Cardiovascular (CV) Thrombotic Events: NSAIDs can increase the risk of serious, and potentially fatal, CV thrombotic events, including myocardial infarction (MI) and stroke. This risk may begin early in treatment and may increase with duration of use and higher doses. Dolacen is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery, and in patients with established congestive heart failure (NYHA Class II–IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease.

  • Gastrointestinal (GI) Adverse Events: NSAIDs cause an increased risk of serious, and potentially fatal, GI inflammation, bleeding, ulceration, and perforation of the stomach or intestines. These events can occur at any time without warning symptoms. Older patients and those with a prior history of GI disease are at a greater risk.

  • Pregnancy: Use of Dolacen is contraindicated starting at about 30 weeks gestation and later due to the risk of premature closure of the fetal ductus arteriosus.


Other Clinically Significant Adverse Reactions

Additional serious or clinically important adverse reactions that require monitoring include Hepatotoxicity (liver enzyme elevations, liver failure), Renal Toxicity (kidney function impairment, hyperkalemia), Hypertension, and Heart Failure (fluid retention/edema).

Hypersensitivity reactions, including anaphylaxis, severe skin reactions (e.g., Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) have been reported.

Commonly reported side effects often involve the GI system (e.g., nausea, abdominal pain, dyspepsia, diarrhea, dizziness, headache, and flatulence) which typically occur more frequently than placebo in clinical trials. Patients with a history of asthma sensitive to aspirin or other NSAIDs must not use Dolacen.

Overdose and Emergency Response

Overdose and When to Seek Help

This section summarizes the official information regarding overdose for the active ingredient in Dolacen (Diclofenac) as documented in governmental regulatory sources.

Immediate action is required if an overdose is suspected.

Documented Overdose Manifestations

System Affected Officially Listed Symptoms and Signs
Gastrointestinal (GI) Nausea, vomiting (sometimes with blood), epigastric pain/stomach pain, diarrhea, and potential GI bleeding.
Central Nervous System (CNS) Headache, drowsiness, dizziness, confusion, agitation, and tinnitus (ringing in the ears).

Severe and Life-Threatening Outcomes

Official regulatory documents indicate that severe overdose, though often presenting with only mild symptoms initially, can lead to serious complications. These rare but severe outcomes include acute renal failure, seizures, coma, significant gastrointestinal bleeding, and cardiovascular effects (e.g., changes in heart rate or blood pressure).

Emergency Action and Management

  • Required Action: You must seek emergency medical attention right away and contact your local Poison Control Center. This action is mandated for all suspected overdoses.
  • Antidote: There is no specific antidote for Diclofenac overdose documented in official labeling.
  • Supportive Measures: Management is symptomatic and supportive. Procedures may include administering activated charcoal, gastric lavage, and monitoring vital signs and organ function through tests like an ECG and blood/urine analyses.
  • Population Note: A large overdose is officially noted to be very harmful to both children and adults, and outcomes can be more severe in those with pre-existing organ impairment.

Therapeutic Uses of Dolacen

What Dolacen Treats: Main Uses and Benefits

The generic compound is commonly used to help with symptoms related to inflammatory processes and symptoms associated with acute or episodic changes. The medication is primarily applied across domains where additional symptomatic support is needed, helping address symptom clusters that may become intense or disruptive.

The compound is considered relevant for managing conditions involving inflammatory processes such as Osteoarthritis and Rheumatoid Arthritis. It is also commonly used to help with severe, episodic manifestations like high-intensity migraine headaches and acute episodes of gout. The compound is relevant for easing symptoms that interfere with daily functioning, including joint swelling, stiffness, and persistent physical discomfort. It may assist with providing supportive relief during difficult episodes of heightened discomfort.

It is commonly used to help with symptoms related to heightened physiological activity like menstrual cramps (dysmenorrhea) and fever. This provides support that contributes to easing the overall symptom load and contributes to improved comfort during periods of heightened symptoms.


Quick Facts: Symptomatic Management

Area of Use Symptom Relief Focus
Chronic Conditions Persistent joint pain, stiffness, and swelling in arthritis.
Acute Episodes High-intensity pain from migraine, gout, or colic.
Episodic Relief Cramping associated with primary dysmenorrhea and fever.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Dolacen is a Nonsteroidal Anti-inflammatory Drug (NSAID) whose eligibility for use is strictly defined by regulatory documents, primarily excluding patients with specific health conditions or sensitivities.

Populations Who Must Not Use Dolacen (Contraindications)

Dolacen is formally contraindicated and must not be used by patients who have a:

  • Known Hypersensitivity: History of an allergic-type reaction (e.g., asthma, hives, or anaphylaxis) after taking aspirin, other NSAIDs, or any component of the drug product.
  • Cardiovascular Surgery: Need for relief of perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Late-Stage Pregnancy: Women from approximately 30 weeks gestation onward.
  • Established Cardiovascular Disease (Systemic Use): Patients with established Ischaemic Heart Disease, Peripheral Arterial Disease, Cerebrovascular Disease, or Congestive Heart Failure (NYHA Class II-IV) are strictly excluded from using systemic (oral, injectable) formulations by some major regulatory bodies (EMA).

Eligibility Restrictions and Special Considerations

Use is generally avoided or requires caution in patients with:

  • Advanced Renal Disease or Severe Heart Failure, unless the expected benefits are determined to outweigh the risk of worsening the condition.
  • Pediatric Patients: Safety and effectiveness are not established for most systemic formulations in children under the age of 18; age-specific rules apply to certain formulations/indications.
  • Hepatic Impairment: Requires careful consideration and monitoring of liver function.

What should I know about interactions with other medicines?

The official regulatory documents for Dolacen (Diclofenac) define its interaction profile through documented patterns of heightened risk and pharmacokinetic changes. Use is formally contraindicated for managing pain in the peri-operative setting of Coronary Artery Bypass Graft (CABG) surgery.

Co-administration with several medicinal product categories is documented to increase the risk of serious complications, primarily due to pharmacodynamic risk reinforcement. This includes all Anticoagulants and Antiplatelet Agents, SSRIs (Selective Serotonin Reuptake Inhibitors), and Systemic Corticosteroids, where the risk of gastrointestinal bleeding or hemorrhage is significantly elevated. Combining Dolacen with Aspirin or other systemic NSAIDs is also not generally recommended.

Pharmacokinetic and Efficacy Interactions

Interactions documented in regulatory labeling also involve exposure modification or efficacy diminution. Dolacen is shown to increase the serum concentrations of co-administered Lithium, Digoxin, and Methotrexate, raising the potential for toxicity of these agents. Conversely, Dolacen may diminish the antihypertensive effect of ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), and Diuretics. This particular interaction carries a specific caution, as the risk of renal deterioration is heightened in elderly or volume-depleted patients on these blood pressure medications.

Drug-Product Restrictions

Consumption of alcohol is documented to increase the risk of gastrointestinal bleeding. Furthermore, a specific oral solution formulation of Diclofenac requires administration on an empty stomach to ensure optimal effectiveness, as food can cause a reduction in the drug's intended action.

Mechanism of Action

Pharmacodynamic Mechanism of Dolacen

Dolacen, containing Diclofenac, functions primarily through the non-selective, competitive inhibition of the Cyclooxygenase (COX) enzyme system (specifically COX-1 and COX-2). This molecular interaction prevents the enzymes from catalyzing the conversion of Arachidonic Acid into proinflammatory mediators, primarily prostaglandins. This suppression of eicosanoid synthesis is the core mechanism.

At the peripheral level, the resultant low concentration of prostaglandins, such as PGE2, reduces the sensitization threshold of peripheral nociceptors (pain-sensing nerve endings), thereby modulating afferent nociceptive signal transmission. This molecular cascade also limits the prostaglandin-mediated increase in vascular permeability and fluid leakage, which affects localized fluid extravasation at the tissue level.

Centrally, the drug acts within the hypothalamus, the brain's thermoregulation center. Inhibition of PGE2 synthesis in this region allows the centrally elevated thermal set-point to be restored, which constitutes the physiological basis for thermal regulation.

Dosage and Administration Information

How Dolacen (Diclofenac) Is Used: Official Administration Guidelines

Dolacen, containing the active substance Diclofenac, is administered according to a strict protocol. Its use is determined by the dosage form and the target route of administration.


Official Routes and Forms of Administration

Route of Administration Approved Forms
Oral Immediate-Release (IR) tablets, Delayed-Release (DR) tablets, Extended-Release (ER) tablets, Capsules, Oral powder for solution.
Parenteral Injectable solutions (Intravenous [IV] bolus/infusion, Intramuscular [IM]).
Topical Gels, Solutions, Patches.
Rectal Suppositories.

Dosing and Procedural Instructions

Official instructions mandate that the lowest effective dose be used for the shortest duration possible. Dosing regimens vary significantly by form and are precisely defined:

  • Standard Oral Dosing: Typically ranges from 100 mg to 150 mg total daily dose in divided doses for chronic conditions (e.g., 50 mg two to three times daily, or 100 mg once daily for ER forms). Acute pain may utilize different short-term, higher-frequency regimens.
  • Administration Conditions: Delayed-Release and Extended-Release tablets must be swallowed whole and must not be crushed or chewed. Some specific capsule forms must be taken on an empty stomach. The oral powder requires mixing only with a small amount of plain water.
  • IV Administration: Intravenous bolus doses (e.g., 37.5 mg) must be administered over at least 15 seconds; patients must be well hydrated prior to injection. Use in advanced renal or hepatic impairment is generally not recommended.

These instructions constitute the standardized, mandatory protocol for administering the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dolacen


Evidence for Symptomatic Management of Chronic Arthritis Conditions

Research for Osteoarthritis (OA) and Rheumatoid Arthritis (RA) primarily involved Randomized Controlled Trials (RCTs) and systematic reviews focusing on Adults and Older Adults. These studies examined standardized measurements of pain intensity and scales tracking reported changes in daily functioning or activity level. Findings describe patterns observed in the studies where the measurements of pain scores and functional metrics shifted during the observation period. Similar research explored symptomatic relief in Ankylosing Spondylitis (AS), monitoring outcomes related to spinal pain and stiffness.


Evidence for the Relief of Acute and Episodic Pain

The evidence base for acute, high-intensity pain and Primary Dysmenorrhea involved numerous short-term RCTs. These studies measured outcomes related to the speed of symptom change and the magnitude of reported pain reduction in the initial hours. For acute pain, studies reported measurements related to the incidence of requiring additional pain medication during the short term. However, the evidence for this acute use is based on very short-term follow-up durations, often just a single dose.


Key Limitations and Uncertainties

The research applies only to the specific populations studied, and subgroup findings are uncertain for many conditions. Follow-up durations were limited in many efficacy trials, which means comparative evidence for sustained maintenance of function over many years is lacking. Furthermore, the research primarily explored how discomfort and function were measured; it is not yet clear whether the compounds affect the long-term progression of underlying chronic diseases.

Frequently Asked Questions (FAQ)

Common questions about Dolacen (FAQ)

Q: What kind of pain or conditions is Dolacen used for?

According to the official product information, Dolacen is indicated for the symptomatic relief of mild to moderate pain. This includes common conditions such as headache, dental pain, and menstrual cramps (dysmenorrhea), as well as reducing fever.

Q: Can I take Dolacen if I have an allergy to common pain relievers?

Regulatory documents state that Dolacen is contraindicated if there is a known allergy to the active substance or any of its ingredients. This also applies if there is a history of gastrointestinal bleeding or perforation related to previous use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Q: Can I take Dolacen at the same time as my other pain relief medicine?

Official information states that the concurrent use of Dolacen with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is generally not recommended. This is because combining these medicines, including COX-2 inhibitors, increases the risk of adverse effects.

Q: Is it safe to use Dolacen if I have asthma?

Official information indicates that Dolacen should be used with caution in individuals with a history of asthma or allergic disease. In some people with these conditions, the medicine may precipitate a sudden narrowing of the airways.

Q: How long can I safely take this medication?

Product information recommends using the lowest effective dose for the shortest duration necessary to control symptoms. This is a standard regulatory statement intended to minimize the potential for side effects with long-term use.

Q: Will Dolacen make me drowsy or affect my ability to drive?

Specific studies on driving ability have not been conducted. However, because the medicine may cause dizziness or drowsiness in some people, patients experiencing these symptoms should avoid driving or operating machinery.

Q: Can children take Dolacen?

Regulatory documents state that Dolacen is not recommended for use in children under 12 years of age. The safety and appropriate dose for individuals under this age have not been established.

Q: Should I take Dolacen with food or on an empty stomach?

Taking Dolacen with food can slightly delay the absorption of the medicine. This may result in a slightly delayed onset of pain relief, but the overall effect is still achieved as indicated in the product documentation.

Q: Does Dolacen affect the liver or kidneys?

Official information indicates that if signs of hepatic (liver) or renal (kidney) impairment occur, discontinuation of Dolacen is advised. These organs are monitored, and patients with pre-existing conditions affecting them require careful consideration.

How should Dolacen be stored and disposed of?

How to Store and Dispose of Diclofenac (Dolacen)

The storage and disposal of Diclofenac products must strictly follow official regulatory guidelines to maintain potency and ensure safety.

Storage Requirements

Category Official Regulatory Requirements
Temperature Store oral tablets at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), not to exceed 30 C (86 F).
Protection Tablets must be protected from light and moisture and stored in a tight, light-resistant container. The topical gel must not be frozen.
Child Safety The medicine must be kept out of the sight and reach of children and pets.

Disposal Instructions

Disposal of unused or expired product must be in accordance with local regulatory requirements. Patients are advised to return expired products to a pharmacist for proper handling. Release to the environment, such as flushing down wastewater, must be avoided.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dolacen found in:

A-Z Index: